In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Eli Lilly's migraine treatment wins U.S. FDA approval

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co's migraine drug, Reyvow. The drug has been approved to treat acute migraine with or

Depression, anxiety may cause patients to leave cardiac rehab

By Linda Carroll (Reuters Health) - Anxiety and depression are common among participants in cardiac rehab programs, and that poor mental health may cause them to drop out, a new study finds. One in

U.S. regulators allow genetically modified cotton as human food source

By Will Dunham WASHINGTON (Reuters) - U.S. regulators on Friday gave the green light for genetically modified cotton to be used for human consumption, paving the way for a protein-packed new food

International donors 'stand with' LGBT+ Ugandans over 'Kill the Gays' bill

By Nita Bhalla NAIROBI (Thomson Reuters Foundation) - Major donors of aid to Uganda including the United States and the European Union said on Friday they were closely examining a plan by the east

Ohio ban on Down syndrome abortion blocked by U.S. appeals court

By Jonathan Stempel (Reuters) - A divided federal appeals court on Friday said Ohio cannot enforce a 2017 law banning abortions when medical tests show that a fetus has Down syndrome. Upholding a

Vitamins, omega-3 supplements may improve autism symptoms

By Lisa Rapaport (Reuters Health) - Children with autism who take supplements of vitamins and omega-3 fatty acids may have fewer symptoms than kids who don't, a meta-analysis suggests. Researchers

Caregivers usually OK with teens answering sensitive health-screening questions

By Anne Harding NEW YORK (Reuters Health) - Most caregivers are comfortable allowing adolescents to independently complete electronic screening tools that address sensitive topics like sex and

'Executive physicals' at top-ranked hospitals may lack recommended screenings

By Lisa Rapaport (Reuters Health) - Executive physicals may lure corporate clients and wealthy individuals with the promise of personalized attention and comprehensive preventive care, but a new study

Miro1 reducer promising in Parkinson's disease models

By David Douglas NEW YORK (Reuters Health) - Studies in induced pluripotent stem cells from patients with Parkinson's disease (PD) and in fruit flies suggest that the mitochondrial protein Miro1 could

Clinical features should drive management of rare dyslipidemias

By Will Boggs MD NEW YORK (Reuters Health) - Clinical features, rather than genotype, should drive clinical management of patients with rare dyslipidemias, according to a new consensus statement from

Hearing aids may help delay dementia, depression in elders

By Vishwadha Chander (Reuters Health) - For older adults, hearing aids may delay some forms of mental and physical decline associated with hearing loss and aging, a U.S. study suggests. Among people

Sex-specific cutoffs for mild cognitive impairment improve diagnostic accuracy

By Reuters Staff NEW YORK (Reuters Health) - Current diagnostic cutoffs for amnesiac mild cognitive impairment (aMCI) lead to underdiagnosis of women and overdiagnosis of men, according to new

Reynolds American files for FDA review of e-cigarette

By Reuters Staff (Reuters) - British American Tobacco Plc unit Reynolds American Inc on Friday became the first major company to confirm it had filed for a U.S. Food and Drug Administration review of

U.S. health officials say vaping illness may have multiple causes

By Julie Steenhuysen and Saumya Joseph (Reuters) - U.S. health officials said on Friday there may be more than one cause behind the nationwide outbreak of serious lung illnesses linked to vaping, and

MMP-7 accurately diagnoses biliary atresia

By Marilynn Larkin NEW YORK (Reuters Health) - Matrix metalloproteinase-7 (MMP-7) shows "good accuracy" in diagnosing biliary atresia (BA) and "holds great promise" as a marker to differentiate BA

Multigene testing for all breast cancer patients cost-effective for UK, US: study

By Marilynn Larkin NEW YORK (Reuters Health) - Expanding genetic testing to all women with breast cancer is "extremely" cost-effective for the US and UK and could prevent thousands of breast or

Ranibizumab, aflibercept appear in breast milk after intravitreal injection

By Will Boggs MD NEW YORK (Reuters Health) - The anti-vascular endothelial growth factor (VEGF) agents ranibizumab and aflibercept are excreted in breast milk following intravitreal injection,

Unpredictable income may be bad for brain health

By Lisa Rapaport (Reuters Health) - Young adults who don't earn the same amount of money from year to year, or who weather substantial pay cuts, do worse on brain health assessments in midlife

"Alarming upsurge" in measles has devastating impact, WHO warns

By Kate Kelland LONDON (Reuters) - Measles is staging a devastating comeback in epidemics across the world as the virus exploits dangerous gaps in vaccination coverage, World Health Organization (WHO)

Trump EPA proposes overhaul of lead in drinking water rule, critics call plan weak

By Timothy Gardner WASHINGTON (Reuters) - The Trump administration on Thursday proposed retooling a 1991 rule on lead and cooper contamination in drinking water, but critics said the change slows by

U.S. migrant policy sends thousands of children including hundreds of babies back to Mexico

By Kristina Cooke, Mica Rosenberg and Reade Levinson TIJUANA, Mexico (Reuters) - Since January, the U.S. government has ordered 13,000 migrants under 18, including more than 400 infants, to wait with

Fewer C-sections when low-risk deliveries handled by midwives

By Linda Carroll (Reuters Health) - Low-risk pregnant women who deliver in a hospital and receive care from midwives have fewer interventions and fewer cesarean sections than similar women who receive

Yellow fever immunity wanes rapidly after vaccination during infancy

By Will Boggs MD NEW YORK (Reuters Health) - Many children vaccinated against yellow fever in infancy lose immunity within a few years after vaccination, according to a longitudinal study. "The

A third of patients with severe asthma are taking risky doses of oral steroids

By Reuter Staff NEW YORK (Reuters Health) - About a third of patients with severe asthma in the Netherlands are taking harmful doses of oral steroids, and poor access to biologic drugs could be

New transplant research aims to salvage infected donated organs

By Caroline Copley and Canice Leung (Reuters) - Retired subway and bus driver Stanley De Freitas had just celebrated his 70th birthday when he started coughing, tiring easily and feeling short of

In European ICUs, fewer deaths are preceded by life-prolonging therapy

By Marilynn Larkin NEW YORK (Reuters Health) - End-of-life care practices in European ICUs have changed over the past two decades, with more limitations on life-prolonging therapies, researchers say.

Australian clinicians uncertain about managing risk-reducing bilateral salpingo-oophorectomy

By Marilynn Larkin NEW YORK (Reuters Health) - A survey of Australian healthcare professionals managing premenopausal women at high genetic risk for ovarian cancer revealed uncertainty surrounding

Reports of antidepressant harms largely unsupported

By Marilynn Larkin NEW YORK (Reuters Health) - Adverse health outcomes associated with antidepressant use may be exaggerated and not supported by evidence, according to the authors of a systematic

Amid vaping crisis, U.S. to issue new advice for doctors focused on lung infections

By Julie Steenhuysen CHICAGO (Reuters) - U.S. health officials are preparing to release new guidance for doctors stressing the need to ask every patient with an apparent respiratory infection about

U.S. vaping-related deaths rise to 26, illnesses to 1,299

By Reuters Staff (Reuters) - U.S. health officials on Thursday reported 26 deaths and 1,299 confirmed and probable cases so far from a mysterious respiratory illness tied to vaping. Last week, the

Men who conceive with assisted reproduction at increased prostate cancer risk

By Lisa Rapaport (Reuters Health) - Men who conceive children using assisted reproduction techniques (ART) like in vitro fertilization (IVF) are more likely to develop prostate cancer and may benefit

REFILE-More U.S. heart disease patients may be choosing to die at home

(Corrects affiliation in paragraph 14 to PIH, from PHI) By Linda Carroll (Reuters Health) - Fewer U.S. patients with cardiovascular disease are dying in hospitals and more of them are dying at home, a

Healthier diet may help lift depression symptoms

By Carolyn Crist (Reuters Health) - Young adults who eat poorly and feel depressed might be able to perk themselves up by switching to a healthier diet, a small study suggests. In a randomized trial,

Several factors linked to outcomes of male breast cancer

By Reuters Staff NEW YORK (Reuters Health) - Several factors are independently associated with better or worse overall survival in men with breast cancer, according to new findings. Male breast cancer

Congo's Ebola outbreak slows but still entrenched in insecure areas - WHO

By Stephanie Nebehay GENEVA (Reuters) - The Ebola epidemic in northeastern Democratic Republic of Congo has been confined to a rural area rife with militias and people on the move, making it harder to

Blood test helps identify pneumonia patients at risk for acute respiratory failure or sepsis

By Megan Brooks NEW YORK (Reuters Health) - A blood test can identify a subgroup of pneumonia patients at increased risk for developing acute respiratory failure or sepsis, according to new research.

Microneedle beta-lactam biosensor passes first-in-human test

By Anne Harding NEW YORK (Reuters Health) - A solid microneedle biosensor can continuously monitor penicillin levels in extracellular fluid (ECF) in real-time, a new proof-of-concept study in healthy

Higher risk of hypertension, cardiovascular events seen with ibrutinib use

By Will Boggs MD NEW YORK (Reuters Health) - Initiation of ibrutinib therapy is associated with an increased risk of hypertension and subsequent cardiovascular events, according to a database study. "

Etiology of acute flaccid myelitis possibly viral

By David Douglas NEW YORK (Reuters Health) - The rare polio-like illness acute flaccid myelitis (AFM) may be virus-related, according to a new U.S. study. In 2014 several cases of the disease were

U.S. urged to 'turn off hate' after suicide of LGBT+ teen

By Rachel Savage NEW YORK (Thomson Reuters Foundation) - The suicide of a 16-year-old who was cyberbullied over sexually explicit messages he exchanged with another boy shows acceptance - including

Gene testing firm gets 25-year ban in $42.6 mln kickback settlement

By Jonathan Stempel (Reuters) - A New Orleans-based genetics testing company and its three principals will pay $42.6 million to resolve charges they defrauded the federal government by paying

Medical education not covering basics of nutrition

By Lisa Rapaport (Reuters Health) - Although diet plays a huge role in health and wellness and can be crucial to managing many common chronic conditions, medical schools tend not to devote much time

Study finds no benefit in faster, slower rates of feeding in preterm babies

By Gene Emery (Reuters Health) - The debate over how quickly to increase the milk intake for preterm infants has new evidence suggesting that speed doesn't seem to matter. In tests of two increments,

Second leading cause of death in children, firearms attract few U.S. research dollars

By Linda Carroll (Reuters Health) - Few federal dollars are available for research into ways to prevent firearm injuries even though they are the second-leading cause of death among U.S. children and

Stroke rates continue to decline in the U.S.

By Carolyn Crist (Reuters Health) - Rates of stroke among U.S. adults over age 65 have steadily decreased over the past 30 years, according to a study that tracked participants from the 1980s through

Drinking more soda and juice tied to increased diabetes risk

By Lisa Rapaport (Reuters Health) - People who increase their consumption of sodas, juices and other sweet drinks over time are more likely than those who don't to develop type 2 diabetes, a U.S.

Dozens caged and shackled in Trinidad drug rehab center, police say

By Linda Hutchinson-Jafar PORT OF SPAIN (Reuters) - Dozens of people were found on Wednesday in squalid conditions, chained and in cages in a Trinidad and Tobago rehabilitation center run by a

Biopsy mass spectrometry identifies malignant potential of thyroid nodules

By Will Boggs MD NEW YORK (Reuters Health) - Mass-spectrometry imaging of fine-needle aspiration (FNA) biopsies can accurately identify the malignant potential of thyroid nodules, researchers report.

Tape strips might replace biopsy to assess skin biomarkers in kids with atopic dermatitis

By Megan Brooks NEW YORK (Reuters Health) - Tape strips may serve as a minimally invasive approach to assess skin biomarkers in children with atopic dermatitis (AD) and also to predict treatment

Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal

By Brendan Pierson and Nate Raymond NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that

'Striking' difference in discontinuation for mini-, standard-size IUDs

By Reuters Staff NEW YORK (Reuters Health) - Women fitted with a standard-sized "gold standard" intrauterine device (IUD) are twice as likely to have stopped using it at one year compared with women

High-flow nasal oxygen with ventilation curbs extubation failure

By David Douglas NEW YORK (Reuters Health) - In ICU patients at high risk of postextubation respiratory failure, noninvasive ventilation (NIV) along with high-flow nasal oxygen applied immediately

Alibaba to stop sales of e-cigarette components in United States

By Josh Horwitz (Reuters) - Chinese e-commerce firm Alibaba said on Wednesday it will stop selling e-cigarette components in the United States, amid growing regulatory scrutiny and reports of lung

Trump administration proposes changes to anti-kickback rules for healthcare

By Carl O'Donnell (Reuters) - The Trump administration on Wednesday proposed changes to federal anti-kickback provisions that restrict the kinds of patient referrals doctors can make, saying it will

For LGBT people outside U.S. Supreme Court, cases have a familiar ring

By Maria Caspani WASHINGTON (Reuters) - For many of the activists who demonstrated outside the U.S. Supreme Court during arguments in major gay and transgender rights cases on Tuesday, the story told

Perioperative dietary therapy beneficial in IBD

By Reuters Staff NEW YORK (Reuters Health) - People with inflammatory bowel disease (IBD) who undergo surgery fare better if they receive perioperative dietary therapy, according to a new research

Elevated infection risk among MS patients differs by treatment

By Will Boggs MD NEW YORK (Reuters Health) - Patients with multiple sclerosis (MS) face an increased risk of infection that differs according to the disease-modifying therapies (DMTs) they receive,

FDA approves Clinuvel's rare genetic disorder treatment, shares at record high

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration approved Australian drugmaker Clinuvel Pharmaceuticals Ltd's treatment for a rare inherited disorder that causes skin damage from

High cost of robot-assisted cholecystectomy should discourage use

By Will Boggs MD NEW YORK (Reuters Health) - Robot-assisted cholecystectomy appears to be safe, but has no added benefit and costs much more than traditional laparoscopic cholecystectomy, according to

Drinking by prospective fathers tied to infant heart defects

By Lisa Rapaport (Reuters Health) - Fathers who drink alcohol in the months just before their child is conceived are more likely to have a baby with heart defects than those who abstain prior to

One quarter of every U.S. healthcare dollar wasted

By Linda Carroll (Reuters Health) - About a quarter of the dollars spent on healthcare in the U.S. may be wasted, a new analysis suggests. Six types of waste in healthcare could be costing as much as

Democratic presidential hopeful Sanders says he was 'dumb' to ignore health warnings

By Simon Lewis WASHINGTON (Reuters) - U.S. Senator Bernie Sanders said on Tuesday he had wrongly ignored warning signs about his health before suffering a heart attack last week, but that he did not

Unexpectedly high malignancy rates in subsolid lung nodules

By Will Boggs MD NEW YORK (Reuters Health) - The malignancy rates of Lung-RADS category-2 and category-3 subsolid lung nodules are much higher than reported, according to an analysis of nodules from

Diabetics can reduce heat illness from exercise

By Lisa Rapaport (Reuters Health) - Diabetes can make people more prone to heat stroke when they exercise on hot days, but two studies suggest there are things diabetics and others can do to lower

Dog ownership linked with longer life, especially for heart patients

By Anne Harding (Reuters Health) - Dog owners live longer, and canine companionship may be especially good for people with heart disease and those living alone, new research shows. "We studied more

Impaired mobility a 'geriatric biomarker' for decline after heart attack

By Reuters Staff NEW YORK (Reuters Health) - Mobility impairment, measured during hospitalization, is a "geriatric biomarker" for functional decline in adults 65 and older who suffer acute myocardial

UPDATE 1-GSK recalls popular heartburn drug Zantac globally after cancer scare

(Updates headline, first paragraph; adds company comment) By Reuters Staff (Reuters) - GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "

Childhood BCG vaccination may curb lung cancer later

By David Douglas NEW YORK (Reuters Health) - A 60-year follow-up of a clinical trial involving American Indian and Alaska Native schoolchildren shows a marked reduction in lung cancer in those who

COPD intervention linked to more, not fewer, hospitalizations

By Will Boggs MD NEW YORK (Reuters Health) - An intervention for patients with chronic obstructive pulmonary disease (COPD) that combines transitional care and long-term self-management support is

Cracks in Purdue's proposed opioid settlement as Arizona backs out

By Reuters Staff (Reuters) - The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine

UPDATE 1-Swedish hospital sounds all clear after testing patient for Ebola

(Adds tests show no sign of Ebola virus) By Reuters Staff STOCKHOLM (Reuters) - Medical tests on a patient in southern Sweden for possible Ebola have detected no sign of the deadly virus, hospital

UPDATE 1-CDC says STD cases in U.S. rose to record high in 2018 as funding lags

(Adds source URL at bottom) By Reuters Staff (Reuters) - The number of Americans who were diagnosed with a sexually transmitted disease (STD) last year rose to a record high, U.S. health officials

Certain cardiovascular disease guidelines may prevent more adverse events

By Marilynn Larkin NEW YORK (Reuters Health) - Among five major primary prevention guidelines, three identify candidates for statin therapy more accurately and reduce atherosclerotic cardiovascular

CDC says STD cases in U.S. rose to record high in 2018 as funding lags

By Reuters Staff (Reuters) - The number of Americans who were diagnosed with a sexually transmitted disease (STD) last year rose to a record high, U.S. health officials said on Tuesday, partly because

Deaths often miscategorized in FDA device-experience database

By Will Boggs MD NEW YORK (Reuters Health) - Many deaths related to two cardiac devices are miscategorized as lesser adverse events in the U.S. Food and Drug Administration (FDA)'s Manufacturer and

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

By Reuters Staff (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines

REFILE-Novartis gets FDA boost in crowded eye drug market

(Corrects global sales figure for Eylea to $6.4 billion, not $4.1 billion, in 10th paragraph) By John Miller and John Revill ZURICH (Reuters) - Novartis's anti-blindness medicine Beovu has become the

Mortality from antineutrophil cytoplasmic autoantibody-associated vasculitis falling slightly

By Will Boggs MD NEW YORK (Reuters Health) - Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from

Sharp declines in rates of surgery among infants

By Anne Harding NEW YORK (Reuters Health) - Children under 3 are less likely to undergo surgery today than they were two decades ago, with the largest drop seen in infants, according to new research.

Swedish hospital tests patient for Ebola, infection 'unlikely'

By Reuters Staff STOCKHOLM (Reuters) - A hospital in southern Sweden said on Tuesday it was testing a patient for Ebola who had come in with a fever after travelling in an infected area. It was

FEATURE-End of statelessness in sight for Shona as Kenya issues birth certificates

By Maina Waruru NAIROBI, Kenya (Thomson Reuters Foundation) - Happiness Kapota will remember forever the day when her children lined up in Nairobi to receive their birth certificates. Joyce, Caleb and

REFILE-Humira, Rituxan top list of U.S. drugs with biggest price increases -report

(Corrects spelling to Nina Varghese from Nin Varghese in paragraph 7, removes "update 1" from slug) By Caroline Humer NEW YORK (Reuters) - AbbVie Inc's arthritis drug Humira and Roche Holding AG's

Qiagen CEO quits amid genetic sequencing U-turn, shares tumble

By Reuters Staff FRANKFURT (Reuters) - Qiagen's longtime CEO Peer Schatz resigned after the German genetic testing company disclosed a reversal of its genome sequencing strategy and a slump in its

Novartis gets FDA boost in crowded eye drug market

By John Miller and John Revill ZURICH (Reuters) - Novartis's anti-blindness medicine Beovu has become the latest eye drug to win U.S. Food and Drug Administration approval, giving the Swiss drugmaker

40,000 toy soldiers highlight plight of injured British veterans

By Reuters Staff MANCHESTER, England (Reuters) - An installation of 40,000 miniature toy soldiers in a shopping center in Manchester, northern England, highlights the plight that many British soldiers

Humira, Rituxan top list of U.S. drugs with biggest price increases -report

By Caroline Humer NEW YORK (Reuters) - AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes

Two school districts sue Juul over vaping 'epidemic'

By Brendan Pierson NEW YORK (Reuters) - Two public school districts on Monday sued Juul Labs Inc, accusing the company of endangering their students and draining their resources by marketing its

Democrat lawmaker introduces bill to cap nicotine content in vapes

By Reuters Staff (Reuters) - A U.S. lawmaker on Monday introduced a bill that seeks to regulate e-cigarette makers by capping the amount of nicotine in the vapes they manufacture to make them less

Paralyzed man hails 'feat' of walking again with robot exoskeleton

By Reuters Staff GRENOBLE, France (Reuters) - The French tetraplegic man who has been able to walk again using a pioneering four-limb robotic system, or exoskeleton, said walking was a major feat for

U.S. Supreme Court takes major case that could curb abortion access

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Friday agreed to take up a major abortion case that could lead to new curbs on access to the procedure as it considers the legality

Youth suicide attempts often involve over-the-counter painkillers

By Lisa Rapaport (Reuters Health) - Young people who attempt suicide by poisoning often use antidepressants or over-the-counter medicines like acetaminophen, ibuprofen and aspirin, a U.S. study

Gay, transgender rights in spotlight as U.S. Supreme Court returns

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court kicks off its new term this week, with a major dispute on tap over whether a landmark decades-old federal anti-discrimination law that

Adverse impact of clinician burnout on patient care might be exaggerated

By Will Boggs MD NEW YORK (Reuters Health) - Many reports seem to have exaggerated the adverse impact of health care provider burnout on quality of care, according to a systematic review and

More U.S. heart disease patients may be choosing to die at home

By Linda Carroll (Reuters Health) - Fewer U.S. patients with cardiovascular disease are dying in hospitals and more of them are dying at home, a new analysis suggests. Between 2003 and 2017, among the

Teen depression risk lower in close-knit families

By Lisa Rapaport (Reuters Health) - Teens with positive family relationships may be less likely to develop depression during adolescence or early adulthood, a new study suggests. Researchers followed

Oral contraceptives linked to depressive symptoms in teens

By Marilynn Larkin NEW YORK (Reuters Health) - Teenage users of oral contraceptive pills (OCP), particularly 16-year-olds, had higher concurrent depressive symptoms than their nonuser peers in an

IBD patients have high exposure to ionizing radiation

By Marilynn Larkin NEW YORK (Reuters Health) - Patients in Ontario with inflammatory bowel disease (IBD), and particularly those with Crohn's disease (CD), are at risk for high exposure to ionizing

In-home initiation of non-invasive ventilation for COPD patients safe, feasible

By Scott Baltic NEW YORK (Reuters Health) - For patients with chronic obstructive pulmonary disease (COPD) and stable hypercapnic respiratory failure, initiating chronic non-invasive ventilation (NIV)

Rising rate of infective endocarditis tied to U.S. opioid epidemic

By Carolyn Crist (Reuters Health) - As the opioid epidemic continues in the U.S., more cases of drug-abuse-related infective endocarditis are being seen, researchers say. Between 2002 and 2016, rates

Longer-term nevirapine exposure doesn't affect infant growth

By Reuters Staff NEW YORK (Reuters Health) - Extended nevirapine prophylaxis does not affect growth in HIV-exposed, uninfected (HEU) breastfeeding infants, according to new findings. "It is reassuring

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.